Dr. Adams can be reached via the Gut-Brain Axis Therapeutics website or the ASU website. He has an email list for updates on studies. https://gutbrainaxistherapeutics.com/

The next MTT study is planned for about a year from now, pending funding for a Phase 3 study.

Analutos provides comprehensive metabolite testing. A simple urine test kit can be ordered to analyze various markers.

Yes, shipping is available internationally, but confirm with the provider for specific regions.

Post-treatment, test results often normalize or show significant improvement, but may vary by individual.

Supplements can be mixed with chocolate, juice, or other foods. Capsules are easier for children who can swallow them.

Both are generally well-tolerated. A small percentage of individuals may have adverse reactions to supplements or antibiotics in MTT due to bacterial toxin release.

While primarily for autism, some participants with ADHD showed improvement. There's potential for addressing depression, anxiety, OCD, and other conditions.

ANRC is safe for children as young as two. MTT studies have gradually lowered the age requirement, now including children four years and older.

MTT has shown no adverse effects for participants with controlled seizures. In one case, a participant with Tourette's saw significant improvement.

Each dose undergoes rigorous safety testing, including donor screening. Over 8,000 treatments for other conditions showed no serious adverse effects.

Yes, the studies are conducted nationwide, with remote participation and no need for in-person visits.

Yes, pre-screening ensures compatibility with existing treatments. Specific screenings depend on the study protocol.

Yes, studies indicate improvements in speech and communication post-treatment.

This was not directly addressed, but natural probiotics and gut health interventions are generally encouraged.

The focus is on significant symptom improvement rather than a cure.